Friday, 29 March 2024
First Trust Nasdaq Pharmaceuticals ETF
-
Overlay
-
Indicators
-
Settings
-
Period
07:33 | 31/1/18
Market Realist
The changes in analysts' recommendations and estimates for JNJ's target price are based on the changes in the trends of its stock price, as well as developments and changes in the company's performance.
more»
07:45 | 26/1/18
Frisco Fastball
More notable recent First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) news were published by: Nasdaq.com which released: “AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2017” on October 11, 2017, also Nasdaq.
more»
04:00 | 26/1/18
Market Realist
Viagra's revenues are expected to decline in 4Q17 due to lower sales in US markets. It revenues could be partially offset by increased sales from international markets.
more»
09:03 | 14/1/18
Finance News Daily
Jan 13 is a positive day so far for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) as the ETF is active during the day after gaining 0.65% to hit $22.46 per share.
more»
06:15 | 11/1/18
Market Realist
Of these 23 analysts, 14 analysts recommend a “buy” while nine analysts recommend a “hold.” None of the analysts recommend a “sell.
more»
Radius Health Inc shares are currently trading up about 4.8% on the day. The chart below shows the one year performance of RDUS shares, versus its 200 day moving average: Radius Health Inc 200 Day Moving Average Chart.
more»
10:55 | 8/1/18
Finance News Daily
Jan 7 is a positive day so far for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) as the ETF is active during the day after gaining 0.2752% to hit $21.86 per share.
more»
05:18 | 30/12/17
Market Realist
... advanced soft tissue sarcoma, reported revenues of $54 million in 3Q17. US sales were $42 million, and international sales were $12 million.
more»
09:37 | 27/12/17
Market Realist
Johnson & Johnson's (JNJ) pulmonary hypertension portfolio earned revenues of $670 million in 3Q17. In 3Q17, in the US and outside the US (international markets), JNJ's pulmonary hypertension portfolio generated revenues of $357 million and $283 ...
more»
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst ...
more»